US FDA inspection at Alembic Pharmaceuticals Limited' Oral Solid Formulation Facility at Panelav

Alembic Pharmaceuticals Limited has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for the inspection carried out by them at our Oral Solid Formulation Facility (F-I) from 17th July, 2024 to 26th July, 2024.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 1192.65 as compared to the previous close of Rs. 1195.90. The total number of shares traded during the day was 17616 in over 1703 trades.

The stock hit an intraday high of Rs. 1206.90 and intraday low of 1176.15. The net turnover during the day was Rs. 21002358.00.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 EIR USFDA OralSolidFormulationFacility